$INO INOVIO and IVI Partner with Seoul National University Hospital to Start Phase 1/2 Clinical Trial of INOVIO's COVID-19 DNA Vaccine (INO-4800) in South Korea 

$MRNA $SRNE $MRK $GILD $CODX $NVAX $JNJ $AMGN $ALT $PFE $CYDY $GSK $ADPT $BNTX $REGN

https://t.co/rWkFx66pEb